Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

Hepatology

Volumn 27, Issue 1, 1998, Pages 240-244

  Kuzushita, N ^a   Hayashi, N ^a   Moribe, T ^a   Katayama, K ^a   Kanto, T ^a   Nakatani, S ^a   Kaneshige, T ^a   Tatsumi, T ^a   Ito, A ^a   Mochizuki, K ^a   Sasaki, Y ^a   Kasahara, A ^a   Hori, M ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ADULT; ANTIGEN PRESENTATION; ARTICLE; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031962298     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270136     Document Type: Article

References (35)

1. 1 Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non‐A, non‐B viral hepatitis genome. Science 1989 ; 244: 359–362. MEDLINE
2. 2 Seeff LB, Buskell‐Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollingger FB, et al. Long‐term mortality after transfusion associated non‐A, non‐B hepatitis. N Engl J Med 1992 ; 327: 1906–1911. MEDLINE
3. 3 Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, et al. Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990 ; 12: 671–675. MEDLINE
4. 4 Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet 1993 ; 341: 464–465. MEDLINE
5. 5 Kuzushita N, Hayashi N, Katayama K, Hiramatsu N, Yasumaru M, Murata H, Shimizu Y, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996 ; 48: 1–7. MEDLINE
6. 6 Ceppellini R, Frumento G, Ferrara GB, Tosi R, Chersi A, Pernis B. Binding of labelled influenza matrix peptide to HLA DR in living B lymphoid cells. Nature 1989 ; 339: 392–394. MEDLINE
7. 7 Benichou G, Takizawa PA, Ho PT, Killion CC, Olson CA, McMillan M, Sercarz EE. Immunogenicity and tolerogenicity of self‐major histocompatibility complex peptides. J Exp Med 1990 ; 172: 1341–1346. MEDLINE
8. 8 Tiwari JL, Terasaki PI. HLA and disease associations. Heidelberg, Germany: Springer‐Verlag. 1989 ; 31–169.
9. 9 Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hapatitis: human leukocyte antigens DR4 and A1‐B8‐DR3 are independent risk factors. Hepatology 1991 ; 13: 701–706. MEDLINE
10. 10 Fujisawa T, Ikegami H, Kawaguchi Y, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, et al. Class I HLA is associated with age‐at‐onset of IDDM, while class II HLA confers susceptibility to IDDM. Diabetologia 1995 ; 38: 1493–1495. MEDLINE
11. 11 Steel CM, Ludlam CA, Beatson D, Peutherer JF, Cuthbert RJG, Simmonds P, Morrison H, et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV‐related disease. Lancet 1988 ; i: 1185–1188.
12. 12 van Hattum J, Schreuder GM, Schalm SW. HLA antigens in patients with various courses after hepatitis B virus infection. Hepatology 1987 ; 7: 11–14. MEDLINE
13. 13 Thursz MR, Kwiatkowski D, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995 ; 332: 1065–1069. MEDLINE
14. 14 Hatae K, Kimura A, Okubo R, Watanabe H, Erlich HA, Ueda K, Nishimura Y, et al. Genetic control of nonresponsiveness to hepatitis B vaccine by an extended HLA haplotype. Eur J Immunol 1992 ; 22: 1899–1905. MEDLINE
15. 15 Hashimoto M, Kinoshita T, Yamasaki M, Tanaka H, Imanishi T, Ihara H, Ichikawa Y, et al. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 1994 ; 44: 166–173. MEDLINE
16. 16 Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. In: HLA 1991: proceedings of the eleventh international histocompatibility workshop and conference. Vol. 1. Oxford, England: Oxford University Press. 1992 ; 1065–1074.
17. 17 Desmet VJ, Gerber M, Hoofnagle JY, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994 ; 19: 1513–1520. MEDLINE
18. 18 Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, et al. Prediction interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 1994 ; 39: 977–982. MEDLINE
19. 19 Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, et al. A proposed system for the nomenclature of hepatitis C virus genotypes. Hepatology 1994 ; 19: 1321–1324. MEDLINE
20. 20 Lau JYN, Davis GL, Kniffen J, Qian K‐P, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993 ; 341: 1501–1504. MEDLINE
21. 21 Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA‐A, ‐B, ‐C, and ‐D antigens. Am J Clin Pathol 1978 ; 69: 103–120. MEDLINE
22. 22 Kaneshige T, Hashimoto M, Matsumoto Y, Kinoshita T, Hirasawa T, Uchida K, Inoko H. Serologic and nucleotide sequencing analyses of a novel DR52‐associated DRB1 allele with the DR'NJ25' specificity, designated DRB1*1307. Hum Immunol 1994 ; 41: 151–159. MEDLINE
23. 23 Moribe T, Kaneshige T, Hirakata M, Mimori T, Akitsuki M, Inoko H. Identification of a DRB1*0405 variant (DRB1*04052) using the PCR‐RFLP method. Tissue Antigens 1996 ; 47: 450–453. MEDLINE
24. 24 Sengar DP, Goldstein R. Comprehensive typing of DQB1 alleles by PCR‐RFLP. Tissue Antigens 1994 ; 43: 242–248. MEDLINE
25. 25 Kaneshige T, Takagi K, Nakamura S, Hirasawa T, Sada M, Uchida K. Genetic analysis using fingernail DNA. Nucleic Acids Res 1992 ; 20: 5489–5490. MEDLINE
26. 26 Olerup O, Aldener A, Fogdell A. HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours. Tissue Antigens 1993 ; 41: 119–134. MEDLINE
27. 27 Svejgaard A, Ryder LP. HLA‐genotype distribution and genetic models of insulin‐dependent diabetes mellitus. Ann Hum Genet 1981 ; 45: 293–298. MEDLINE
28. 28 Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956 ; 56: 309–311.
29. 29 Peano G, Menardi G, Ponzetto A, Fenoglio LM. HLA‐DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 1994 ; 154: 2733–2736. MEDLINE
30. 30 Tibbs C, Donaldson PT, Underhill JA, Thomson L, Manabe K, Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV‐infection in Northern European Caucasoids. Hepatology 1996 ; 24: 1342–1345. MEDLINE
31. 31 Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, et al. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993 ; 178: 17–25. MEDLINE
32. 32 Botarelli P, Brunetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo QL, et al. T‐lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993 ; 104: 580–587. MEDLINE
33. 33 Koziel MJ, Dudley D, Afdhal N, Grakoui A, Rice CM, Choo QL, Houghton M, et al. HLA class I‐restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995 ; 96: 2311–2321. MEDLINE
34. 34 McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF‐ promoter region associated with susceptibility to cerebral malaria. Nature 1994 ; 371: 508–511. MEDLINE
35. 35 Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, Goedert JJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV‐1 infection. Nature Med 1996 ; 2: 405–411. MEDLINE